Value Stocks With Rising Earnings Estimates

Conviction: 72% · Horizon: 1Y · 2026-07-14
Low valuations and improving earnings expectations support upside.

Methanex, LATAM Airlines, and Harmony Biosciences combine discounted earnings multiples with recent positive revisions to profit expectations.

Instrument Side Target Reason
FAF Long First American Financial combines a discounted earnings multiple versus its industry with a 7.1% increase in current-year earnings estimates, suggesting improving profit expectations at an attractive valuation.
ALRS Long Alerus Financial offers a near-industry earnings multiple alongside a 13.9% rise in current-year earnings estimates, indicating strengthening fundamentals that are not yet reflected in a premium valuation.
PGY Long Pagaya combines improving current-year earnings expectations with a discounted earnings multiple versus its industry, creating a value-oriented setup backed by positive estimate momentum.
GDOT Long Green Dot shows stronger earnings expectations after recent upward revisions and trades at a much lower earnings multiple than its industry, supporting a contrarian value case.
ECPG Long Encore Capital benefits from rising earnings estimates and a below-industry earnings multiple, suggesting the market may be undervaluing its specialty finance earnings profile.
ECPG Long Encore Capital Group combines a discounted valuation, with a P/E of 6.17 versus 11.60 for its industry, and improving current-year earnings expectations after a 7.4% estimate increase over the past 60 days.
CMCO Long Columbus McKinnon trades at a P/E of 7.37 compared with 24.20 for its industry, while current-year earnings estimates have risen 5% over the past 60 days, suggesting improving fundamentals at a low multiple.
PEB Long Pebblebrook Hotel Trust combines a below-industry earnings multiple with improving current-year earnings expectations, suggesting valuation support alongside better profit momentum.
GDS Long GDS Holdings trades at a sizable earnings-multiple discount to its industry while earnings expectations have risen sharply, creating a value case backed by accelerating profit forecasts.
ALTO Long Alto Ingredients offers a lower earnings multiple than its industry and materially stronger next-year earnings expectations, supporting a recovery-oriented value thesis.
NVGS Long Navigator combines a low earnings multiple with a 29.5% rise in current-year earnings estimates, suggesting improving profitability is not fully reflected in the valuation.
BY Long Byline Bancorp trades at a modest earnings multiple while current-year profit estimates have risen 6.2%, supporting a value case backed by improving fundamentals.
NBIX Long Neurocrine offers exposure to neurological and endocrine therapies at a below-market earnings multiple, with current-year earnings estimates up 14.4% over the past 60 days.
HCI Long HCI Group offers a below-market earnings multiple while current-year earnings expectations have improved, suggesting the market may be underpricing stronger fundamentals in its insurance, technology and real estate operations.
LYB Long LyondellBasell trades at a discount to its industry on earnings while profit expectations have risen sharply, creating a value case backed by improving near-term operating outlook.
LZRFY Long Localiza Rent a Car combines an earnings multiple below its industry average with upward revisions to current-year profit expectations, supporting a constructive view on the Brazilian car rental business.
MEOH Long Methanex offers exposure to methanol and ammonia with improving current-year earnings expectations, while its P/E ratio of 5.62 sits well below the industry multiple of 12.40.
LTM Long LATAM Airlines combines strong upward revisions to current-year earnings expectations with a P/E ratio of 11.21, materially below the broader market multiple cited in the article.
HRMY Long Harmony Biosciences shows improving next-year earnings expectations and trades at a P/E ratio of 11.31, offering a discounted valuation relative to the broader market multiple cited in the article.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.